IRIS

1.5 Abstract in Rivista: [1657] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 321 a 340 di 1.657
Titolo Data di pubblicazione Autore(i) File
TARIBO trial: Targeted therapy with or without nephrectomy in metastatic renal cell carcinoma (mRCC)-Liquid biopsy for biomarkers discovery 1-gen-2016 Verzoni, E; Bearz, A; Bracarda, S; Bregni, M; Buti, S; Cinieri, S; De Giorgi, U; Fornarini, G; Galli, L; Milella, M; Morelli, F; Nole, F; Passalacqua, R; Sabbatini, R; Santini, D; Salvioni, R; Cappelletti, V; Grassi, P; De Braud, Fg; Procopio, G
Overexpression of p53 protein predicts complete response to chemoradiation therapy in T2-T4 bladder cancer: Ten years follow up 1-gen-2007 Brighenti, M; Naldi, N; Caminiti, C; Potenzoni, D; Fumagalli, M; Crafa, P; Buti, S; Passalacqua, R
Outcome of patients with progressing oligometastatic renal cell carcinoma treated with locoregional therapy: a multicenter retrospective analysis 1-gen-2017 De Lisi, D; Maruzzo, M; Galli, L; Biasco, E; Farnesi, A; Procopio, G; Ratta, R; Buti, S; Sternberg, Cn; Cerbone, L; Di Lorenzo, G; Pantano, F; Sterpi, M; De Giorgi, U; Berardi, R; Torinai, M; Camerini, A; Massari, F; Tonini, G; Santini, D
Bevacizumab (B) plus immunotherapy (IT) plus chemotherapy (C) (BIC) in metastatic renal cell cancer (mRCC): results and evaluation of circulating T-regulatory cells (Treg) and other cytokines. A GOIRC study 1-gen-2010 Passalacqua, R; Buti, S; Simonelli, C; Rivoltini, L; Castelli, C; Camisaschi, C; Lo Re, G; Lleshi, A; Donnini, M; Lazzarelli, S
Prognostic factors in patients with pancreatic metastases from renal cell carcinoma (PM-RCC): Room for thinking about the role of surgery? 1-gen-2014 Santoni, M; Conti, A; Porta, C; Cerbone, L; Procoplo, G; Basso, U; De Giorgi, U; Rizzo, M; Ortega, C; Masser, F; Iacovelli, R; Masini, C; Milelia, M; di Lorenzo, G; Pagano, M; Buti, S; Falconi, M; Burattini, L; Santini, D; Cascinu, S
Dose-dense chemotherapy with modified TCF regimen (TCF-DD) in metastatic gastric cancer (MGC): A feasibility study 1-gen-2006 Dalla Chiesa, M; Tomasello, G; Buti, S; Negri, F; Buononato, M; Lazzarelli, S; Donati, G
CORE-URO-01 study: comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure 1-gen-2017 Masini, C; Vitale, Mg; Maruzzo, M; Procopio, G; De Giorgi, U; Buti, S; Rossetti, S; Iacovelli, R; Guida, A; Atzori, F; Mucciarini, C; Scagliarini, S; Vignani, F; Prati, G; Cosmai, L; Berselli, A; Pinto, C
Preliminary results of a factorial phase II randomized trial of continuous (C) or intermittent (I) docetaxel (DOC) with or without estramustine (E) as first-line treatment for castration-resistant prostate cancer (CRPC) (HOPLITE trial) 1-gen-2012 Caffo, O; Lo Re, G; Sava, T; Buti, S; Sacco, C; Basso, U; Zustovich, F; Martini, T; Perin, A; Veccia, A; Russo, L; Facchini, G; Barile, C; Gernone, A; De Vivo, R; Pappagallo, Gl; Galligioni, E
Bevacizumab plus immunotherapy, with interleukin-2 (IL-2) and interferone-alpha (IFN-alpha), plus chemotherapy (BIC), in patients with metastatic renal cell cancer (mRCC). Dose-finding/phase II trial 1-gen-2007 Buti, S; Lazzarelli, S; Simonelli, C; Venturini, S; Spazzapan, S; Lo Re, G; Mattioli, R; Dalla Chiesa, M; Brighenti, M; Mazza, G; Passalacqua, R
CORE-URO-01 study: comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure 1-gen-2017 Masini, C; Vitale, Mg; Maruzzo, M; Procopio, G; De Giorgi, U; Buti, S; Rossetti, S; Iacovelli, R; Guida, A; Atzori, F; Mucciarini, C; Cosmai, L; Vignani, F; Prati, G; Scagliarini, S; Berselli, A; Pinto, C
Dose-dense chemotherapy (CT) with modified dose-dense TCF regimen (TCF-dd) in metastatic gastric cancer (MGC): Update of a phase II study 1-gen-2010 Dalla Chiesa, M; Poli, R; Tomasello, G; Lazzarelli, S; Buti, S; Brighenti, M; Negri, F; Curti, A; Auzzani, A; Passalacqua, R
High efficacy of sequential chemotherapy (CT) with dose-dense modified TCF regimen (TCF-DD) followed by CT with oxaliplatin, folinic acid (FA), 5-fluorouracil (5-FU) and irinotecan (COFFI) in metastatic gastric cancer (MGC) 1-gen-2008 Dalla Chiesa, M; Tomasello, G; Buti, S; Negri, F; Brighenti, M; Lazzarelli, S; Auzzani, A; Curti, A; Martinotti, M; Passalacqua, R
Phase II study of chemotherapy with oxaliplatin (Ox), irinotecan (Ir), levo-folinic acid (L-FA) and 5-fluorouracil (5-FU) (COFFI) in metastatic gastric cancer (MGC) 1-gen-2005 Chiesa, Md; Buti, S; Tomasello, G; Negri, F; Donati, G; Cattaneo, M; Gnocchi, N; Bozzetti, R; Buononato, M; Passalacqua, R
Role of chemotherapy in metastatic renal cell cancer (MRC) resistant to treatment with IL-2 and IFN alpha 1-gen-2006 Brighenti, M; Buti, S; Chiesa, Md; Tomasello, G; Buzio, C; Bongiovanni, C; Alberici, F; Passalacqua, R
Bevacizumab (B) plus low-doses immunotherapy (IT), plus chemotherapy (CT) (BIC), in metastatic renal cell cancer (mRCC): antitumor effects and variations of T-regulatory cells (Treg) and other T lymphocytes subsets. A study of the Italian Oncology Group for Clinical Research (GOIRC) 1-gen-2008 Buti, S; Lazzarelli, S; Rivoltini, L; Castelli, C; Camisaschi, C; Simonelli, C; Lo Re, G; Mattioli, R; Mazza, G; Brighenti, M; Passalacqua, R
Dose-dense chemotherapy (CT) with modified TCF regimen (TCF-DD) in metastatic gastric cancer (MGC): A phase II study 1-gen-2007 Chiesa, Md; Tomasello, G; Buti, S; Negri, F; Buononato, M; Longarini, R; Lazzarelli, S; Brighenti, M; Passalacqua, R
Impact of intermittent (I) first-line docetaxel (D)-based chemotherapy on quality of life (QL) of patients (pts) with castration-resistant prostate cancer (CRPC): Results of a phase II randomized trial 1-gen-2013 Caffo, O; Sava, T; Basso, U; Buti, S; Lo Re, G; Sacco, C; Lodde, M; Facchini, G; Zustovich, F; Perin, A; Russo, L; Veccia, A; Galligioni, E
Dose-dense chemotherapy (CT) with modified dose-dense TCF regimen (TCF-DD) in metastatic gastric cancer (MGC): update of a phase II study 1-gen-2010 Dalla Chiesa, M; Poli, R; Tomasello, G; Lazzarelli, S; Brighenti, M; Negri, F; Curti, A; Auzzani, A; Buti, S; Liguigli, W; Passalacqua, R
Integration of tissue and circulating parameters identifies a favorable immune profile in NSCLC patients treated with nivolumab 1-gen-2018 Mazzaschi, G; Facchinetti, F; Madeddu, D; Buti, S; Gelsomino, F; Ardizzoni, A; Aversa, F; Missale, G; Quaini, F; Tiseo, M
High efficacy of sequential chemotherapy (CT) with dose-dense modified TCF regimen (TCF-DD) followed by CT with Oxaliplatin, Folinic Acid (FA), 5-Fluorouracil (5-FU) and Irinotecan (COFFI) in metastatic gastric cancer (MGC) 1-gen-2008 Dalla Chiesa, M; Tomasello, G; Buti, S; Negri, F; Brighenti, M; Lazzarelli, S; Auzzani, A; Curti, A; Martinotti, M; Passalacqua, R
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 321 a 340 di 1.657
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Articolo su rivista1657
Autore
  • DI MARIO, Francesco242
  • GIULIANI, Nicola126
  • BUTI, Sebastiano112
  • ALBERTINI, Roberto87
  • SEBASTIANI, MARCO78
  • SCARPIGNATO, Carmelo75
  • AGNETTI, Aldo66
  • PARRINO, Liborio66
  • MUSOLINO, Antonino61
  • CARANO, Nicola60
Data di pubblicazione
  • 2020 - 2024117
  • 2010 - 2019802
  • 2000 - 2009512
  • 1990 - 1999174
  • 1980 - 198951
  • 1979 - 19791
Editore
  • ASCO pubs11
  • ELSEVIER9
  • Elsevier7
  • SAGE PUBLICATIONS LTD5
  • Edra3
  • INT UNION CRYSTALLOGRAPHY3
  • LIPPINCOTT WILLIAMS & WILKINS3
  • SPRINGERNATURE3
  • WILEY3
  • BioMed Central2
Rivista
  • DIGESTIVE AND LIVER DISEASE101
  • GASTROENTEROLOGY100
  • BLOOD89
  • ANNALS OF ONCOLOGY78
  • HAEMATOLOGICA56
  • JOURNAL OF CLINICAL ONCOLOGY51
  • NEUROLOGICAL SCIENCES46
  • UNITED EUROPEAN GASTROENTEROLOGY ...46
  • ANNALS OF THE RHEUMATIC DISEASES30
  • REUMATISMO26
Keyword
  • Helicobacter pylori10
  • sclerosi sistemica6
  • Bioengineering5
  • Gastroenterology5
  • HCV5
  • UV5
  • GERD4
  • anodal stimulation3
  • beat-to-beat variability of cardi...3
  • capillaroscopia3
Lingua
  • eng848
  • ita160
  • fre1
Accesso al fulltext
  • no fulltext1625
  • reserved26
  • open6